- Boston Scientific (BSX, Financial) CFO Dan Brennan announces retirement after nearly 30 years.
- Jon Monson, with over 25 years at BSX, set to succeed Brennan as CFO effective June 30, 2025.
- Monson to oversee key financial functions, continuing BSX's strategic leadership.
Boston Scientific Corporation (BSX) has announced the retirement of its long-serving Chief Financial Officer, Dan Brennan, effective at the end of June 2025. Brennan, who joined the company nearly three decades ago, will continue to serve as a senior advisor through early October 2025, ensuring a smooth transition.
Jon Monson, who is currently the senior vice president of Investor Relations, will succeed Brennan as the executive vice president and CFO. Monson, with over 25 years of experience at Boston Scientific, brings a wealth of knowledge, having previously held roles such as global controller and chief accounting officer. His responsibilities will encompass global controllership, internal audit, corporate finance, treasury, corporate tax, investor relations, and corporate business development, among others.
Monson's appointment reflects a well-planned leadership transition, with Mike Mahoney, Chairman and CEO, praising his strategic mindset and proven leadership. Monson played a pivotal role in guiding the company through the 2020 pandemic, showcasing his ability to manage during times of crisis. He is expected to continue driving Boston Scientific's financial strategy and growth initiatives, building on the strong foundation laid by Brennan.
Boston Scientific, a leader in medical technology, has been innovating to improve patient health globally for over 45 years. With Jon Monson stepping into the CFO role, the company aims to continue its trajectory of financial performance and innovation in the healthcare sector.
